Key result
Pre- and post-procedural inflammatory biomarkers, particularly C-reactive protein, are significant predictors of adverse clinical outcomes and restenosis following percutaneous coronary intervention.
Why the study?
Pre- and post-PCI inflammatory status is linked to outcomes, but a targeted understanding of how inflammatory biomarkers differ across balloon angioplasty, bare metal stents, and drug eluting stents is needed.
Answers are grounded in this paper and cite their sources.
Inflammatory biomarkers, particularly CRP, are significant predictors of adverse outcomes following PCI, highlighting the potential need for targeted immunomodulatory therapies to improve patient outcomes.
The role of inflammation in percutaneous coronary intervention (PCI) has been investigated in numerous studies. Both pre-PCI and post-PCI inflammatory status have been demonstrated to be linked with patient outcomes. C-reactive protein continues to be the most studied inflammatory biomarker, while a growing number of additional biomarkers, including cytokines and immune cells, are being assessed. As insights are gained into the complexities of the inflammatory response to PCI, it becomes evident that a targeted approach is necessary to ensure optimal patient outcomes. Here, we review the biomarkers that can predict patient outcomes following PCI and specifically how they differ for balloon angioplasty, bare metal stents and drug eluting stents. A specific focus is given to human studies and periprocedural inflammation rather than inflammation associated with myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Merinopoulos et al. (2022) conducted a review in Percutaneous coronary intervention (PCI). Percutaneous coronary intervention (PCI) was evaluated. Pre- and post-procedural inflammatory biomarkers, particularly C-reactive protein, are significant predictors of adverse clinical outcomes and restenosis following percutaneous coronary intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: